ATE255632T1 - Immortalisierung bzw. desimmortalisierung von zellen - Google Patents
Immortalisierung bzw. desimmortalisierung von zellenInfo
- Publication number
- ATE255632T1 ATE255632T1 AT96918405T AT96918405T ATE255632T1 AT E255632 T1 ATE255632 T1 AT E255632T1 AT 96918405 T AT96918405 T AT 96918405T AT 96918405 T AT96918405 T AT 96918405T AT E255632 T1 ATE255632 T1 AT E255632T1
- Authority
- AT
- Austria
- Prior art keywords
- cells
- immortalization
- disimmertalization
- compositions
- methods
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/162—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from virus
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
- C12N15/90—Stable introduction of foreign DNA into chromosome
- C12N15/902—Stable introduction of foreign DNA into chromosome using homologous recombination
- C12N15/907—Stable introduction of foreign DNA into chromosome using homologous recombination in mammalian cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/10041—Use of virus, viral particle or viral elements as a vector
- C12N2740/10043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/13011—Gammaretrovirus, e.g. murine leukeamia virus
- C12N2740/13041—Use of virus, viral particle or viral elements as a vector
- C12N2740/13043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2800/00—Nucleic acids vectors
- C12N2800/30—Vector systems comprising sequences for excision in presence of a recombinase, e.g. loxP or FRT
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2840/00—Vectors comprising a special translation-regulating system
- C12N2840/20—Vectors comprising a special translation-regulating system translation of more than one cistron
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2840/00—Vectors comprising a special translation-regulating system
- C12N2840/20—Vectors comprising a special translation-regulating system translation of more than one cistron
- C12N2840/203—Vectors comprising a special translation-regulating system translation of more than one cistron having an IRES
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Wood Science & Technology (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Biophysics (AREA)
- Virology (AREA)
- Biochemistry (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Immunology (AREA)
- Mycology (AREA)
- Gastroenterology & Hepatology (AREA)
- Cell Biology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/481,127 US5629159A (en) | 1995-06-07 | 1995-06-07 | Immortalization and disimmortalization of cells |
PCT/US1996/009781 WO1996040877A1 (en) | 1995-06-07 | 1996-06-06 | Immortalization and disimmortalization of cells |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE255632T1 true ATE255632T1 (de) | 2003-12-15 |
Family
ID=23910719
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT96918405T ATE255632T1 (de) | 1995-06-07 | 1996-06-06 | Immortalisierung bzw. desimmortalisierung von zellen |
Country Status (10)
Country | Link |
---|---|
US (1) | US5629159A (de) |
EP (1) | EP0832196B1 (de) |
JP (1) | JP3875267B2 (de) |
AT (1) | ATE255632T1 (de) |
AU (1) | AU700690B2 (de) |
CA (1) | CA2222425C (de) |
DE (1) | DE69630955T2 (de) |
ES (1) | ES2211959T3 (de) |
NO (1) | NO323174B1 (de) |
WO (1) | WO1996040877A1 (de) |
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030202967A1 (en) * | 1995-02-10 | 2003-10-30 | The Regents Of The University Of California | Development and use of human pancreatic cell lines |
US6110743A (en) * | 1995-02-10 | 2000-08-29 | The Regents Of The University Of California | Development and use of human pancreatic cell lines |
FR2737731B1 (fr) * | 1995-08-07 | 1997-10-10 | Pasteur Institut | Sequence de retroelements naturels ou synthetiques ayant pour fonction de permettre l'insertion de sequences nucleotidiques dans une cellule eucaryote |
EP1484409B1 (de) * | 1996-12-16 | 2009-04-08 | Eisai R&D Management Co., Ltd. | DNA-Konstrukt umfassend ein Medikamenten-Resistenzgen und ein fremdes Gen |
CA2276529A1 (en) * | 1996-12-31 | 1998-07-09 | George A. Gaitanaris | Vectors and methods for the mutagenesis of mammalian genes |
DE19740571C1 (de) * | 1997-09-15 | 1999-03-18 | Gsf Forschungszentrum Umwelt | Verfahren zur Stimulation von T-Zellen mit gewünschter Antigenspezifität |
US6897066B1 (en) * | 1997-09-26 | 2005-05-24 | Athersys, Inc. | Compositions and methods for non-targeted activation of endogenous genes |
JP2001520877A (ja) * | 1997-10-28 | 2001-11-06 | プレジデント・アンド・フェロウズ・オブ・ハーバード・カレッジ | 血管平滑筋細胞のインビトロ分化、それに関する方法および試薬 |
DE19816116C2 (de) * | 1998-04-09 | 2000-06-29 | Gsf Forschungszentrum Umwelt | Verfahren zur Immortalisation von Zellen mit Hilfe konditional transformierter Helferzellen |
WO2000018239A1 (en) * | 1998-09-25 | 2000-04-06 | University Of Nebraska Board Of Regents | Reversibly immortalized hepatocytes and methods of use |
AU2515600A (en) | 1999-01-21 | 2000-08-07 | Vitro Diagnostics, Inc. | Immortalized cell lines and methods of making the same |
US6890726B1 (en) | 1999-04-06 | 2005-05-10 | Oklahoma Medical Research Foundation | Method for selecting recombinase variants with altered specificity |
EP1103615A1 (de) * | 1999-11-25 | 2001-05-30 | Universite De Geneve | Vektoren, die nicht-teilende Zellen immortalisieren können und Zellen, die mit diesen Vektoren immortalisiert wurden |
US20040231006A1 (en) * | 2000-04-12 | 2004-11-18 | Silver Daniel P. | Self-extinguishing recombinases, nucleic acids encoding them and methods of using the same |
US6852530B2 (en) | 2000-04-12 | 2005-02-08 | Dana Farber Cancer Institute, Inc. | Self-extinguishing recombinases, nucleic acids encoding them and methods of using the same |
FR2810046B1 (fr) * | 2000-06-07 | 2004-09-10 | Neurotech | Procede d'immortalisation conditionnelle de cellules et les constructions proteiques pour sa mise en oeuvre |
JP4185264B2 (ja) * | 2001-07-02 | 2008-11-26 | 富士フイルム株式会社 | 偏光方向制御素子及び露光装置 |
JP2003033179A (ja) * | 2001-07-05 | 2003-02-04 | Asahi Kasei Corp | 可逆的遺伝子導入ベクター |
US6645763B2 (en) * | 2001-10-12 | 2003-11-11 | Naoya Kobayashi | Immortalized bone marrow mesenchymal stem cell |
GB0300208D0 (en) * | 2003-01-06 | 2003-02-05 | Oxford Biomedica Ltd | Insulin producing cells |
US7485457B2 (en) * | 2003-04-17 | 2009-02-03 | United States Of America Department Of Veterans Affairs | Isolated/cloned human NT2 cell lines expressing serotonin and GABA |
GB0316882D0 (en) | 2003-07-18 | 2003-08-20 | Consejo Superior Investigacion | Reversible immortalization of OEG from human olfactory bulbs as a tool to promote spinal cord regeneration |
US7527971B2 (en) * | 2004-10-20 | 2009-05-05 | Vitro Diagnostics, Inc. | Adult stem cell lines |
US20070093439A1 (en) * | 2005-10-25 | 2007-04-26 | Idera Pharmaceuticals, Inc. | Short immunomodulatory oligonucleotides |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA1293460C (en) * | 1985-10-07 | 1991-12-24 | Brian Lee Sauer | Site-specific recombination of dna in yeast |
US5399346A (en) * | 1989-06-14 | 1995-03-21 | The United States Of America As Represented By The Department Of Health And Human Services | Gene therapy |
WO1992015694A1 (en) * | 1991-03-08 | 1992-09-17 | The Salk Institute For Biological Studies | Flp-mediated gene modification in mammalian cells, and compositions and cells useful therefor |
WO1993001283A1 (en) * | 1991-07-08 | 1993-01-21 | The United States Of America As Represented By The Secretary Of Agriculture | Selection-gene-free transgenic plants |
AU4115693A (en) * | 1992-04-24 | 1993-11-29 | Sri International | In vivo homologous sequence targeting in eukaryotic cells |
JPH08500245A (ja) * | 1992-07-27 | 1996-01-16 | カリフォルニア インスティテュート オブ テクノロジー | 哺乳動物の多能性神経幹細胞 |
US5387237A (en) * | 1992-07-30 | 1995-02-07 | The University Of Toledo | Bioartificial pancreas |
-
1995
- 1995-06-07 US US08/481,127 patent/US5629159A/en not_active Expired - Lifetime
-
1996
- 1996-06-06 AU AU61077/96A patent/AU700690B2/en not_active Ceased
- 1996-06-06 ES ES96918405T patent/ES2211959T3/es not_active Expired - Lifetime
- 1996-06-06 CA CA002222425A patent/CA2222425C/en not_active Expired - Fee Related
- 1996-06-06 DE DE69630955T patent/DE69630955T2/de not_active Expired - Fee Related
- 1996-06-06 WO PCT/US1996/009781 patent/WO1996040877A1/en active Search and Examination
- 1996-06-06 JP JP50200397A patent/JP3875267B2/ja not_active Expired - Fee Related
- 1996-06-06 AT AT96918405T patent/ATE255632T1/de not_active IP Right Cessation
- 1996-06-06 EP EP96918405A patent/EP0832196B1/de not_active Expired - Lifetime
-
1997
- 1997-12-02 NO NO19975557A patent/NO323174B1/no unknown
Also Published As
Publication number | Publication date |
---|---|
ES2211959T3 (es) | 2004-07-16 |
WO1996040877A1 (en) | 1996-12-19 |
DE69630955D1 (de) | 2004-01-15 |
CA2222425A1 (en) | 1996-12-19 |
NO975557L (no) | 1998-02-05 |
EP0832196A1 (de) | 1998-04-01 |
EP0832196B1 (de) | 2003-12-03 |
US5629159A (en) | 1997-05-13 |
CA2222425C (en) | 2007-08-21 |
DE69630955T2 (de) | 2004-10-21 |
JP3875267B2 (ja) | 2007-01-31 |
AU700690B2 (en) | 1999-01-14 |
NO975557D0 (no) | 1997-12-02 |
NO323174B1 (no) | 2007-01-15 |
AU6107796A (en) | 1996-12-30 |
JPH11507230A (ja) | 1999-06-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69630955T2 (de) | Immortalisierung bzw. desimmortalisierung von zellen | |
DE69737735D1 (de) | Immortalisierte zelllinien für die wachstum von viren | |
AR004357A1 (es) | Compuestos de 1-fenil-2-dimetilaminometil-ciclohexan-1-ol, y procedimiento de preparacion para dichos compuestos. | |
TR200100922T2 (tr) | Aktif maddelerin akciğerler yolu ile tatbik edilmesi. | |
ATE413386T1 (de) | Ppar-gamma modulatoren | |
DE122009000012I1 (de) | Substituierte pyrazolyl-benzolsulfonamide zur behandlung von entzundungen. | |
ATE214928T1 (de) | Thrombininhibitoren | |
DK199901519A (da) | I form af små molekyler foreliggende inhibitorer af rotamase-enzymaktivitet | |
PT934325E (pt) | Trisanidridos biciclicos de tetrafosfonato | |
ES2101499T3 (es) | Fibras. | |
MX9800625A (es) | Marcfortinas y paraherquamidas antiparasitarias. | |
DE69905906D1 (de) | Kombination von zwei oder mehreren wirkstoffen unter verwendung von mikrokapsel-formulierungen | |
DE69116550D1 (de) | Steroid-sulfatase-inhibitoren | |
DE69603089D1 (de) | Zusammensetzung zur behandlung von mauerwerk | |
FR2737115B1 (fr) | Composition stable contenant une enzyme | |
DE69405919D1 (de) | Zusammensetzungen zur Behandlung von Keratinfasern | |
MX9602557A (es) | Proteinas de higado de mamifero y su uso en oncologia. | |
NO20001758D0 (no) | Fremgangsmåter og blandinger for behandling av leddgikt | |
DE69834937D1 (de) | Antibiotika zur behandlung von magengeschwuren | |
DE69623493D1 (de) | Enzymatische zusammensetzung | |
ATE165594T1 (de) | Triarylethylenderivate zur therapeutischen verwendung | |
DK0756003T3 (da) | Fremgangsmåde til dyrkning af dyreceller | |
DE69428909D1 (de) | Für die immun- und cns-therapie nutzbare, neuartige tripeptide | |
ITBZ950045A0 (it) | Gioiello e procedimento per la realizzazione dello stesso. | |
MX9709783A (es) | Inmortalizacion y desinmortalizacion de celulas. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |